BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Yuhan secures drug technology transfer deal from American company Processa

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : August 20, 2020, 10:13 | Updated : August 20, 2020, 10:13
  • 트위터
  • 페이스북
  • 웨이보
 

[Courtesy of Yuhan]


SEOUL -- Yuhan, a pharmaceutical and chemical company in South Korea, clinched a deal worth up to $410.5 million to transfer the technology of YH12852, a new drug candidate for the treatment of functional gastrointestinal disease, to Processa Pharmaceuticals, an American pharmaceutical company.

Yuhan will receive Processa shares worth $2 million in down payment as well as royalties and milestone payments, which are paid when each milestone is achieved in clinical trials and commercialization. Processa will secure exclusive rights to the development, manufacture and commercialization of YH12852 in the world except for South Korea.

"Functional gastrointestinal diseases have a great impact on the quality of life," Yuhan CEO Lee Jung-hee said. "We hope that YH12852 can provide patients with more effective treatment options than conventional treatments."

YH12852 acts selectively on certain receptors that play an important role in gastrointestinal motion and sensory functions. Unlike cisapride which was previously licensed as a treatment for functional gastrointestinal diseases, there are few side effects. In pre-clinical toxicity tests and first-phase clinical tests conducted at home, YH12852 showed a clear improvement of bowel movement without cardiovascular side effects.

Processa is to conduct second-phase clinical testing in 2021 for patients who suffer from intestinal obstruction after surgery and constipation, a side effect that occurs when taking a drug-induced painkiller.


 

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Students join hands with Yuhan-Kimberly to make our land greener  .
    Students join hands with Yuhan-Kimberly to 'make our land gr…
  • .Yuhan signs $870 mln technology export deal with Boehringer Ingelheim for NASH treatment.
    Yuhan signs $870 mln technology export deal with Boehringer …
  • .Yuhan to co-develop and sell GI Innovations biologic for treatment of allergic diseases.
    Yuhan to co-develop and sell GI Innovation's biologic for tr…
  • .Yuhan-Kimberly makes foray into adult cosmetics market with anti-pollution skin care brand.
    Yuhan-Kimberly makes foray into adult cosmetics market with …

Real Time Photo News

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

  • .​Solo singer Sunmi to come back with new album Tail.

    ​Solo singer Sunmi to come back with new album 'Tail'

  • .Big Hits live-streaming joint venture gains reinforcements from Universal Music, YG.

    Big Hit's live-streaming joint venture gains reinforcements from Universal Music, YG

Latest News

more+

  • Prime Minister Chung stresses importance of 'borderless communication channel' to minimize informati…
  • State hospital succeeds in inserting wireless pacemakers into hearts of bradyarrhythmia patients
  • LG Electronics' joint venture with Canada's Magna awaits approval by shareholders in March
  • Sajo Seafood to launch raw tuna menu delivery service
  • Researchers find new roundworm species near Dokdo
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view